Changliang Wang
- Molecular Biology top 10%
- Cancer Research top 5%
- Immunology
- Neurology
- Physiology
- Topics
- MicroRNA in disease regulation (7 papers)Cancer-related molecular mechanisms research (6 papers)Parkinson's Disease Mechanisms and Treatments (4 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Changliang Wang
33 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Molecular Biology 819
- Cancer Research 571
- Immunology 67
- Neurology 66
- Physiology 63
Countries citing papers authored by Changliang Wang
This map shows the geographic impact of Changliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changliang Wang more than expected).
Fields of papers citing papers by Changliang Wang
This network shows the impact of papers produced by Changliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changliang Wang. The network helps show where Changliang Wang may publish in the future.
Co-authorship network of co-authors of Changliang Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Changliang Wang. A scholar is included among the top collaborators of Changliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changliang Wang. Changliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 22 | |
| 8 | 13 | |
| 9 | 2 | |
| 10 | 16 | |
| 11 | 21 | |
| 12 | 6 | |
| 13 | 5 | |
| 14 | The bioinformatics toolbox for circRNA discovery and analysisbreakdown → | 266 |
| 15 | 22 | |
| 16 | 18 | |
| 17 | 28 | |
| 18 | 11 | |
| 19 | 29 | |
| 20 | PROGRESS ON THE RESEARCH OF BOWMAN-BIRK SOYBEAN TRYPSIN INHIBITOR | 0 |
About Changliang Wang
Changliang Wang is a scholar working on Aging, Cancer Research and Neurology, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). The work is most often cited by research in Cancer Research (571 citations), Molecular Biology (819 citations) and Aging (15 citations). Changliang Wang has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Liang Chen, Garry Wong, Huiyan Sun, Yang� Yang, Liisa Heikkinen, Yanchun Liang, Juexin Wang, Yan Wang, Menglei Zhang and Yang Yang. Their work appears in journals such as Nature Communications, Scientific Reports and International Journal of Hydrogen Energy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.